These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25101484)

  • 1. Rates and reasons for device-based guideline eligibility in patients with heart failure.
    Lyons KJ; Podder M; Ezekowitz JA
    Heart Rhythm; 2014 Nov; 11(11):1983-90. PubMed ID: 25101484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
    Mehra MR; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; O'Connor CM; Reynolds D; Walsh MN; Fonarow GC
    Heart Rhythm; 2009 Dec; 6(12):1727-34. PubMed ID: 19959119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the underutilization of cardiac resynchronization therapy.
    Bank AJ; Gage RM; Olshansky B
    J Card Fail; 2014 Sep; 20(9):696-705. PubMed ID: 24948569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.
    Mehra MR; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Liu Y; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):135-45. PubMed ID: 22145695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.
    Lyons KJ; Ezekowitz JA; Liang L; Heidenreich PA; Yancy CW; DeVore AD; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2017 May; 5(5):388-392. PubMed ID: 28449799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population-Based Study of Adherence to Guideline Recommendations and Appropriate-Use Criteria for Implantable Cardioverter Defibrillators.
    Bernier R; Al-Shehri M; Raj SR; Reyes L; Lockwood E; Gulamhusein S; Williams R; Valtuille L; Sivakumaran S; Hruczkowski T; Kimber S; Exner DV; Sandhu RK
    Can J Cardiol; 2018 Dec; 34(12):1677-1681. PubMed ID: 30527158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
    Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2008 Jul; 1(2):98-106. PubMed ID: 19808279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF.
    Curtis AB; Yancy CW; Albert NM; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; Oconnor CM; Reynolds D; Walsh MN; Fonarow GC
    Am Heart J; 2009 Dec; 158(6):956-64. PubMed ID: 19958862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.
    Inama G; Pedrinazzi C; Landolina M; Oliva F; Senni M; Proclemer A; Berisso MZ; Pirelli S;
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):675-83. PubMed ID: 22002257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unidentified candidates for cardiac resynchronization therapy: guideline adherence in a large academic outpatient clinic in the Netherlands.
    de Groot JR; Krul SP; Kroon S; Knops RE; Peters RJ; Wilde AA
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):69-75. PubMed ID: 23078171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.